Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ocular surface encompasses the corneal epithelium, conjunctival epithelium, and the overlaying tear film. The corneal epithelium is a non-keratinized, stratified layer of cells that forms the front-most barrier of the cornea, essential for protection and clarity. The tear film is a dynamic, multi-layered fluid (composed of lipid, aqueous, and mucin layers) that lubricates the cornea, provides nutrients, defends against pathogens through antimicrobial proteins, and supplies a smooth refractive surface necessary for vision. Together, these structures maintain the health, transparency, and function of the eye's anterior segment, and disruption leads to common diseases such as dry eye, infections, and inflammatory conditions.
Not applicable (since there is no single molecular target), but relevant drugs may: - Supplement tear film volume or composition (artificial tears) - Suppress inflammation (cyclosporine, corticosteroids) - Block immune cell adhesion (lifitegrast) - Provide antimicrobial activity (antibiotics)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular surface, corneal epithelium, and tear film.